Tell your Story  

Time for Canadians to fight for pharmacare

| August 29, 2012 | 0 Comments

Some estimate a universal pharmacare program could save Canadians up to $10 billion per year

Troy Media – by Steve Morgan and Jamie Daw

universal pharmacare

Universal pharmacare programs available in a number of other countries provides more equitable access to prescription drugs for citizens

When Prime Minister Stephen Harper, along with the Health and Immigration Ministers, tried to justify cutting refugee health coverage in Canada they argued it was about fairness. Providing prescription drug coverage to refugees was unfair, they claimed, because other Canadians do not have such coverage. They were at least partially right.

As a country, we provide universal access to medically necessary hospital care, diagnostic tests, and physician services based solely on need. It’s a point of national pride. But Canadian “medicare” - as it is affectionately known – ends as soon as a patient is given a prescription to fill.

Provincial drug plans cover only limited populations, such as seniors or social assistance recipients, or limited costs (such as costs exceeding “catastrophic” deductibles). Private drug insurance is a perk not easily obtained by Canadians who are retired, self-employed or employees of small companies.

The patchwork of drug coverage in Canada has consequences that cost us all.

A recent study found that one in 10 Canadians can’t afford to fill their prescriptions as directed. Such financial barriers often increase costs elsewhere in the health care system – from the public purse. For example, if a parent cannot afford the necessary drugs for a child’s asthma, they may be forced to visit to the emergency department when the asthma gets out of control.

Thus, the question is not whether it is fair to provide refugees prescription drug coverage; the question is whether it is fair – and even fiscally responsible – not to provide such coverage to all Canadians.

Our recent essay in Healthcare Policy shows how the omission of pharmacare from Canadian medicare was an accident of history – the correction of which is long overdue.

Canada’s health insurance system was developed in stages, starting with the components of healthcare that were the most important at the time. Coverage for hospital care and diagnostic tests was established in the 1950s, followed by coverage for medical care in the 1960s. The fathers of our medicare system intended that pharmacare and homecare be established next.

Pharmacare never happened, but the need for it is stronger than ever.

The range, use and availability of pharmaceuticals has increased dramatically over the past 30 years. As a result, prescription drugs are one of the most important components of contemporary health care. They are also one of the most costly forms of care.

Canadians now spend more money on prescription drugs than they do on all of the services provided by physicians in this country. And while many drugs are available at modest cost, a new wave of biological drugs is coming to market with price tags of thousands of dollars per year – in some cases, thousands of dollars per month.

The need for pharmacare has not gone unnoticed. In 1997, the National Forum on Health recommended expanding pharmacare across Canada, but the pharmaceutical industry lobbied against such reforms, arguing that Canada could not “afford” the cost of a national pharmacare system. Such arguments are repeated today.

In truth, a universal pharmacare program would save Canadians billions of dollars – some estimate up to $10-billion per year.

The proof is found in virtually all countries comparable to Canada: countries like Australia, Denmark, France, Germany, the Netherlands, New Zealand, Norway, Sweden, Switzerland and the United Kingdom. In comparison to Canada, pharmaceutical spending is lower and has been growing more slowly in all of these countries. Yet they all provide better, more equitable access to prescription drugs than Canada through universal pharmacare systems of one form or another.

In the 2012 Emmett Hall Memorial Lecture, Dr. Michael Rachlis said that medicare was one of the best expressions of Canadian democracy because Canadian citizens wanted it and had to fight for it.

If Canadians take pride in their medicare system, and want to achieve better access to medicines at lower costs than they pay today, then maybe it is time for the original vision of medicare – which included pharmacare – to be completed as planned.

Perhaps it is time to fight for pharmacare. Not just for refugees, but for all Canadians.

Steve Morgan is an expert advisor with EvidenceNetwork.ca and Associate Professor and Associate Director of the Centre for Health Services and Policy Research at the University of British Columbia. Jamie Daw is a Policy Analyst with the Centre for Health Services and Policy Research.

© Troy Media

 
Related Posts SliderRelated Stories
Fraser Institute: Gov’t prescription drug regulation provides little benefit for Canadians
A recent Fraser Institute report argues that government intervention in the prescription drug market through regulation, price controls, and public drug insurance programs fails to make prescription drugs more affordable ...
READ MORE
Troy Media - By Mark Rovere Over the past several years, the Ontario government has attempted to rein-in the costs of the province’s publicly-funded drug insurance program by capping prices ...
READ MORE
According to the Canadian Medical Association’s Voices into Action: Report on the National Dialogue on Health Care Transformation report, the Canadian public recognizes he health system does not work as ...
READ MORE
New cancer drugs: Canadians wait almost twice as long as Americans
Report suggests Canadian cancer drugs approval process may be flawed The process for reviewing and approving new cancer drugs in Canada takes almost twice as long as that in the United ...
READ MORE
Through international cooperation of the drug approval process and by replacing bureaucratic public drug plans with private plans and targeted subsidies for those with low incomes, needed drugs could more quickly be made available to those in medical and financial need.
Public drug coverage based on politics Troy Media - by Mark Rovere    Question: Should patients in Rome or Detroit have faster access to new prescription drugs than someone living in Victoria or ...
READ MORE
The debate on health care Canadians are not having
Citizens had better step up because our politicians won't By Bruce A Stewart     Premiers Wall (Saskatchewan) and Ghiz (PEI) led the charge at the end of July to get all ...
READ MORE
Canada’s drug authority takes longer to approve new drugs than Europe or the U.S. A new report from Fraser Institute found that federal and provincial government bureaucracies take more than ...
READ MORE
Fraser Institue: National health spending crunch not fault of drug costs
A new report by the Fraser Institute dispels claims that prescription drug costs are at the root of Canada's health spending crisis.   "There's no evidence linking the unsustainable growth of government ...
READ MORE
Fraser Institute: Gov’t prescription drug regulation provides little
Ontario’s prescription drug coverage should be based on
Canadians feel “moral imperative” to fix health care
New cancer drugs: Canadians wait almost twice as
Easy access to new prescription drugs depends on
The debate on health care Canadians are not
Fraser Institute: Canada drags its heels approving new
Fraser Institue: National health spending crunch not fault

Category: Opinion

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Tell your Story